SCHEMBL7112335

SCHEMBL7112335

CN(C)c1ccc(Nc2nc(Nc3ccc(C(=O)O)cc3)c3nc[nH]c3n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.46
IGF1R P08069 1/20 0.46
CHEK1 O14757 1/20 0.45
NTRK2 Q16620 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPT P10636 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
TOP2A P11388 1/20 0.45
BRAF P15056 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GSK3A P49840 4/20 0.44
ADORA3 P0DMS8 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA1 P30542 1/20 0.44
SYK P43405 1/20 0.41
CSNK2A1 P68400 1/20 0.41
AURKA O14965 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4892691 0.86 ALK (0.55) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL7112340 0.84 GSK3B (0.45) GSK3BCHEK1NTRK2MEN1KMT2A
SCHEMBL7107687 0.82 ALK (0.57) CHEK1NTRK2MEN1KMT2AMAPT
SCHEMBL7108322 0.81 GSK3B (0.50) GSK3BCHEK1NTRK2MEN1KMT2A
SCHEMBL7110570 0.77 POLB (0.55) GSK3BCHEK1NTRK2TOP2ABRAF
SCHEMBL7106217 0.77 GSK3B (0.53) GSK3BMEN1KMT2AMAPTTDP1
SCHEMBL7106210 0.77 GSK3B (0.53) GSK3BMEN1KMT2AMAPTTDP1
SCHEMBL4898620 0.76 ALK (0.61) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL7104854 0.76 SMN1; SMN2 (0.56) MEN1KMT2AMAPTBRAFNPC1
SCHEMBL7105790 0.76 MERTK (0.53) GSK3BTOP2ABRAFADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP claimed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO claimed
EP-1347975-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES Aventis Pharma S.A. (FR) 2003-10-01 EP disclosed
WO-2002051843-A1 NOVEL PURINE DERIVATIVES, PREPARATION METHOD AND USE AS MEDICINES AVENTIS PHARMA S.A. (FR) 2002-07-04 WO disclosed